Profile
International Journal of Community & Family Medicine Volume 1 (2016), Article ID 1:IJCFM-107, 3 pages
https://doi.org/10.15344/2456-3498/2016/107
Mini Review
Brain Natriuretic Peptide in Cirrhosis

Ana Lanca Bastiancic1* and Sandra Milic2

1Department of Cardiology, Thalassotherapia Opatija, Clinic for treatment, rehabilitation and prevention of cardiovascular disease, Opatija,Croatia
2Department of Gastroenterology, University of Rijeka School of Medicine, University Hospital Centre Rijeka, Rijeka, Croatia
Dr. Ana Lanca Bastiancic, Department of Cardiology, Thalassotherapia Opatija, Clinic for treatment, rehabilitation and prevention of cardiovascular disease, Opatija, Croatia, Tel: +385958621080; E-mail: analanca22@gmail.com
21 January 2016; 23 April 2016; 25 April 2016
Bastiancic AL, Milic S (2016) Brain Natriuretic Peptide in Cirrhosis. Int J Community Fam Med 1: 107. doi: https://doi.org/10.15344/2456-3498/2016/107

Abstract

Brain natriuretic peptide (BNP) is well known cardiac hormone released from the left ventricle myocardium as result of heart wall injury. It is a often used biochemical marker of heart failure. Its greatest role is in distinguishing etiology of dyspnea. The role of BNP in cirrhotic patients is not fully explored jet. It is well known that cirrhosis leads to diastolic and consequently systolic dysfunction, causing increase of BNP values. BNP could be a good follow up marker in cirrhotic patients, and a marker od liver decompensation, since its values positively correlate with Child Pough score, and other complications of liver cirrhosis. There are more studies needed in this field.